Barbara Gayle Duncan Immunomedics Inc (IMMU) insider trading activity

Barbara Gayle Duncan is Director of IMMUNOMEDICS INC. Currently has a direct ownership of 0 shares of IMMU, which is worth approximately $0. The most recent transaction as insider was on Oct 23, 2020, when has been sold 49,244 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Barbara Gayle Duncan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 23 2020	SELL Sale (or disposition) back to the issuer	-	49,244 Reduced 100.0%	0 Common Stock

Also insider at

AVIR

Atea Pharmaceuticals, Inc. Healthcare

FUSN

Fusion Pharmaceuticals Inc. Healthcare

OVID

Ovid Therapeutics Inc. Healthcare

Director

JNCE

Jounce Therapeutics, Inc. Healthcare

Director

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

HALO

HALOZYME THERAPEUTICS, INC. Healthcare

BGD